We studied the effect of chronic morphine administration on the circulating dendritic cell population dynamics associated with SIV infection using rhesus macaques. Animals were either first infected with SIV and then given chronic morphine, or visa versa. SIV infection increased the numbers of myeloid DCs (mDCs), but morphine treatment attenuated this mDC expansion. In contrast, morphine increased the numbers of plasmacytoid DCs (pDCs) in SIV-infected animals. Finally, chronic morphine administration (no SIV) transiently increased the numbers of circulating pDCs. These results show that chronic morphine induces a significant alteration in the available circulating levels of critical antigen-presenting cells.
Introduction
Dendritic cells (DCs) are a critical component of the early response to infectious agents, and play an important role in both innate and adaptive immune responses. These cells can play both positive (protective) and negative roles in the host response to HIV (or SIV) infection. It is well established that DCs are capable of expressing CD4 and most of the chemokine co-receptors, including both CCR5 and CXCR4, which are the major co-receptors involved in HIV attachment (Granelli-Piperno et al., 1996; Rubbert et al., 1998; Ignatius et al., 2000; Turville et al., 2001) . While DCs are susceptible to infection, it appears that the level of viral replication in these cells is relatively low (Cameron et al., 1992; McIlroy et al., 1995; Pope et al., 1995) , due in part to the low level of CD4 and coreceptor expression (Wu and KewalRamani, 2006; Liu et al., 2009a) . Because of their vigorous migratory activity, DCs spread the virus to lymph node compartments where T cells can eventually become infected. It is apparent that DCs transmit the virus to T cells during the process of cognate antigen-presentation resulting in preferential infection of HIV-specific CD4-positive T cells (Douek et al., 2002; Lore et al., 2005; Moris et al., 2006) . There is evidence that HIV/SIV infection results in reduced DC function, and this appears to be due to a period of reduced absolute numbers of circulating DCs, as well as reduced functional activity of these cells (Pacanowski et al., 2001; Donaghy et al., 2003; Chehimi et al., 2007) . For example, peripheral blood DCs from HIV-infected patients exhibit less efficient stimulation of T cells, suggesting that these cells fail to carry out antigenpresentation at a normal level (Macatonia et al., 1990; Knight et al., 1991) . Moreover, recent studies show that HIV-infected DCs induce elevated levels of the immunosuppressive cytokine IL-10 (GranelliPiperno et al., 2004), which would be expected to attenuate antigen-driven T cell activation induced through the DCs.
There are two major subsets of DCs: CD11c-positive myeloid DCs (mDCs), and CD11c-negative plasmacytoid DCs (pDCs) (O'Doherty et al., 1994; Robinson et al., 1999; Shortman and Liu, 2002) . These cell populations express distinct collections of TLRs and exhibit divergent cytokine expression profiles in response to activation (Liu et al., 2009a) . Both populations of DCs express high levels of MHC class II proteins, costimulatory molecules, and are efficient antigen-presenting cells. The pDCs express TLR7 and TLR9, and respond to bacterial and viral RNA and DNA by producing very high levels of type I interferon (IFN) (Asselin-Paturel et al., 2001; Kadowaki et al., 2001; Liu, 2005) . These cells are capable of strong antiviral activity by virtue of the IFN Journal of Neuroimmunology 295-296 (2016) 30-40 
